nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—CYP3A4—bone cancer	0.827	1	CbGaD
Buspirone—Eye pain—Epirubicin—bone cancer	0.000559	0.00416	CcSEcCtD
Buspirone—Mental disability—Doxorubicin—bone cancer	0.000559	0.00416	CcSEcCtD
Buspirone—Vision blurred—Cisplatin—bone cancer	0.000558	0.00415	CcSEcCtD
Buspirone—Cardiac failure congestive—Epirubicin—bone cancer	0.000557	0.00414	CcSEcCtD
Buspirone—Tremor—Cisplatin—bone cancer	0.000555	0.00413	CcSEcCtD
Buspirone—Cerebrovascular accident—Methotrexate—bone cancer	0.000551	0.0041	CcSEcCtD
Buspirone—Ill-defined disorder—Cisplatin—bone cancer	0.00055	0.00409	CcSEcCtD
Buspirone—Increased appetite—Epirubicin—bone cancer	0.000538	0.004	CcSEcCtD
Buspirone—Malaise—Cisplatin—bone cancer	0.000534	0.00398	CcSEcCtD
Buspirone—Leukopenia—Cisplatin—bone cancer	0.00053	0.00395	CcSEcCtD
Buspirone—Dermatitis bullous—Epirubicin—bone cancer	0.000528	0.00393	CcSEcCtD
Buspirone—Eye pain—Doxorubicin—bone cancer	0.000518	0.00385	CcSEcCtD
Buspirone—Cerebrovascular accident—Epirubicin—bone cancer	0.000515	0.00384	CcSEcCtD
Buspirone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000515	0.00384	CcSEcCtD
Buspirone—Convulsion—Cisplatin—bone cancer	0.000513	0.00382	CcSEcCtD
Buspirone—Mood swings—Methotrexate—bone cancer	0.000511	0.00381	CcSEcCtD
Buspirone—Ataxia—Methotrexate—bone cancer	0.000507	0.00378	CcSEcCtD
Buspirone—Myalgia—Cisplatin—bone cancer	0.000504	0.00375	CcSEcCtD
Buspirone—Discomfort—Cisplatin—bone cancer	0.000498	0.00371	CcSEcCtD
Buspirone—Increased appetite—Doxorubicin—bone cancer	0.000497	0.0037	CcSEcCtD
Buspirone—Affect lability—Epirubicin—bone cancer	0.000497	0.0037	CcSEcCtD
Buspirone—Dermatitis bullous—Doxorubicin—bone cancer	0.000489	0.00364	CcSEcCtD
Buspirone—Face oedema—Epirubicin—bone cancer	0.000488	0.00363	CcSEcCtD
Buspirone—Oedema—Cisplatin—bone cancer	0.000483	0.0036	CcSEcCtD
Buspirone—Mood swings—Epirubicin—bone cancer	0.000478	0.00356	CcSEcCtD
Buspirone—Cerebrovascular accident—Doxorubicin—bone cancer	0.000477	0.00355	CcSEcCtD
Buspirone—Ataxia—Epirubicin—bone cancer	0.000475	0.00353	CcSEcCtD
Buspirone—Thrombocytopenia—Cisplatin—bone cancer	0.000473	0.00352	CcSEcCtD
Buspirone—Tachycardia—Cisplatin—bone cancer	0.000472	0.00351	CcSEcCtD
Buspirone—Hyperhidrosis—Cisplatin—bone cancer	0.000467	0.00348	CcSEcCtD
Buspirone—Dry skin—Epirubicin—bone cancer	0.000463	0.00345	CcSEcCtD
Buspirone—Eosinophilia—Methotrexate—bone cancer	0.000462	0.00344	CcSEcCtD
Buspirone—Anorexia—Cisplatin—bone cancer	0.000461	0.00343	CcSEcCtD
Buspirone—Affect lability—Doxorubicin—bone cancer	0.00046	0.00342	CcSEcCtD
Buspirone—Hypotension—Cisplatin—bone cancer	0.000452	0.00336	CcSEcCtD
Buspirone—Face oedema—Doxorubicin—bone cancer	0.000451	0.00336	CcSEcCtD
Buspirone—Muscular weakness—Epirubicin—bone cancer	0.000445	0.00332	CcSEcCtD
Buspirone—Mood swings—Doxorubicin—bone cancer	0.000443	0.00329	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00044	0.00328	CcSEcCtD
Buspirone—Ataxia—Doxorubicin—bone cancer	0.000439	0.00327	CcSEcCtD
Buspirone—Dysuria—Methotrexate—bone cancer	0.000436	0.00325	CcSEcCtD
Buspirone—Paraesthesia—Cisplatin—bone cancer	0.000434	0.00323	CcSEcCtD
Buspirone—Eosinophilia—Epirubicin—bone cancer	0.000432	0.00322	CcSEcCtD
Buspirone—Dyspnoea—Cisplatin—bone cancer	0.000431	0.00321	CcSEcCtD
Buspirone—Erectile dysfunction—Methotrexate—bone cancer	0.00043	0.0032	CcSEcCtD
Buspirone—Dry skin—Doxorubicin—bone cancer	0.000428	0.00319	CcSEcCtD
Buspirone—Decreased appetite—Cisplatin—bone cancer	0.00042	0.00313	CcSEcCtD
Buspirone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000417	0.00311	CcSEcCtD
Buspirone—Drowsiness—Methotrexate—bone cancer	0.000416	0.0031	CcSEcCtD
Buspirone—Depression—Methotrexate—bone cancer	0.000415	0.00309	CcSEcCtD
Buspirone—Pain—Cisplatin—bone cancer	0.000413	0.00308	CcSEcCtD
Buspirone—Muscular weakness—Doxorubicin—bone cancer	0.000412	0.00307	CcSEcCtD
Buspirone—Dysuria—Epirubicin—bone cancer	0.000408	0.00304	CcSEcCtD
Buspirone—Conjunctivitis—Methotrexate—bone cancer	0.000404	0.00301	CcSEcCtD
Buspirone—Pollakiuria—Epirubicin—bone cancer	0.000403	0.003	CcSEcCtD
Buspirone—Eosinophilia—Doxorubicin—bone cancer	0.0004	0.00298	CcSEcCtD
Buspirone—Sweating—Methotrexate—bone cancer	0.000399	0.00297	CcSEcCtD
Buspirone—Feeling abnormal—Cisplatin—bone cancer	0.000398	0.00296	CcSEcCtD
Buspirone—Weight increased—Epirubicin—bone cancer	0.000397	0.00296	CcSEcCtD
Buspirone—Weight decreased—Epirubicin—bone cancer	0.000395	0.00294	CcSEcCtD
Buspirone—Epistaxis—Methotrexate—bone cancer	0.000392	0.00292	CcSEcCtD
Buspirone—Drowsiness—Epirubicin—bone cancer	0.000389	0.0029	CcSEcCtD
Buspirone—Body temperature increased—Cisplatin—bone cancer	0.000382	0.00284	CcSEcCtD
Buspirone—Conjunctivitis—Epirubicin—bone cancer	0.000378	0.00282	CcSEcCtD
Buspirone—Dysuria—Doxorubicin—bone cancer	0.000378	0.00281	CcSEcCtD
Buspirone—Haemoglobin—Methotrexate—bone cancer	0.000375	0.00279	CcSEcCtD
Buspirone—Haemorrhage—Methotrexate—bone cancer	0.000373	0.00278	CcSEcCtD
Buspirone—Sweating—Epirubicin—bone cancer	0.000373	0.00278	CcSEcCtD
Buspirone—Pollakiuria—Doxorubicin—bone cancer	0.000373	0.00278	CcSEcCtD
Buspirone—Weight increased—Doxorubicin—bone cancer	0.000368	0.00274	CcSEcCtD
Buspirone—Epistaxis—Epirubicin—bone cancer	0.000367	0.00273	CcSEcCtD
Buspirone—Weight decreased—Doxorubicin—bone cancer	0.000365	0.00272	CcSEcCtD
Buspirone—Drowsiness—Doxorubicin—bone cancer	0.00036	0.00268	CcSEcCtD
Buspirone—Hypersensitivity—Cisplatin—bone cancer	0.000356	0.00265	CcSEcCtD
Buspirone—Bradycardia—Epirubicin—bone cancer	0.000356	0.00265	CcSEcCtD
Buspirone—Haemoglobin—Epirubicin—bone cancer	0.000351	0.00261	CcSEcCtD
Buspirone—Conjunctivitis—Doxorubicin—bone cancer	0.00035	0.00261	CcSEcCtD
Buspirone—Haemorrhage—Epirubicin—bone cancer	0.000349	0.0026	CcSEcCtD
Buspirone—Tinnitus—Methotrexate—bone cancer	0.000348	0.00259	CcSEcCtD
Buspirone—Hypoaesthesia—Epirubicin—bone cancer	0.000348	0.00259	CcSEcCtD
Buspirone—Asthenia—Cisplatin—bone cancer	0.000347	0.00258	CcSEcCtD
Buspirone—Sweating—Doxorubicin—bone cancer	0.000345	0.00257	CcSEcCtD
Buspirone—Epistaxis—Doxorubicin—bone cancer	0.00034	0.00253	CcSEcCtD
Buspirone—Chills—Methotrexate—bone cancer	0.000335	0.00249	CcSEcCtD
Buspirone—Diarrhoea—Cisplatin—bone cancer	0.000331	0.00246	CcSEcCtD
Buspirone—Alopecia—Methotrexate—bone cancer	0.00033	0.00246	CcSEcCtD
Buspirone—Bradycardia—Doxorubicin—bone cancer	0.000329	0.00245	CcSEcCtD
Buspirone—Tinnitus—Epirubicin—bone cancer	0.000326	0.00242	CcSEcCtD
Buspirone—Erythema—Methotrexate—bone cancer	0.000325	0.00242	CcSEcCtD
Buspirone—Haemoglobin—Doxorubicin—bone cancer	0.000325	0.00242	CcSEcCtD
Buspirone—Flushing—Epirubicin—bone cancer	0.000324	0.00241	CcSEcCtD
Buspirone—Haemorrhage—Doxorubicin—bone cancer	0.000323	0.00241	CcSEcCtD
Buspirone—Hypoaesthesia—Doxorubicin—bone cancer	0.000322	0.00239	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—bone cancer	0.000318	0.00237	CcSEcCtD
Buspirone—Chills—Epirubicin—bone cancer	0.000314	0.00233	CcSEcCtD
Buspirone—Alopecia—Epirubicin—bone cancer	0.000309	0.0023	CcSEcCtD
Buspirone—Vomiting—Cisplatin—bone cancer	0.000307	0.00229	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—bone cancer	0.000306	0.00228	CcSEcCtD
Buspirone—Rash—Cisplatin—bone cancer	0.000305	0.00227	CcSEcCtD
Buspirone—Dermatitis—Cisplatin—bone cancer	0.000305	0.00227	CcSEcCtD
Buspirone—Erythema—Epirubicin—bone cancer	0.000304	0.00226	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—bone cancer	0.000302	0.00224	CcSEcCtD
Buspirone—Tinnitus—Doxorubicin—bone cancer	0.000301	0.00224	CcSEcCtD
Buspirone—Flushing—Doxorubicin—bone cancer	0.0003	0.00223	CcSEcCtD
Buspirone—Flatulence—Epirubicin—bone cancer	0.0003	0.00223	CcSEcCtD
Buspirone—Tension—Epirubicin—bone cancer	0.000298	0.00222	CcSEcCtD
Buspirone—Dysgeusia—Epirubicin—bone cancer	0.000298	0.00222	CcSEcCtD
Buspirone—Nervousness—Epirubicin—bone cancer	0.000295	0.0022	CcSEcCtD
Buspirone—Malaise—Methotrexate—bone cancer	0.000293	0.00218	CcSEcCtD
Buspirone—Muscle spasms—Epirubicin—bone cancer	0.000292	0.00218	CcSEcCtD
Buspirone—Vertigo—Methotrexate—bone cancer	0.000292	0.00217	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—bone cancer	0.000291	0.00217	CcSEcCtD
Buspirone—Chills—Doxorubicin—bone cancer	0.00029	0.00216	CcSEcCtD
Buspirone—Nausea—Cisplatin—bone cancer	0.000287	0.00214	CcSEcCtD
Buspirone—Vision blurred—Epirubicin—bone cancer	0.000287	0.00213	CcSEcCtD
Buspirone—Alopecia—Doxorubicin—bone cancer	0.000286	0.00213	CcSEcCtD
Buspirone—Ill-defined disorder—Epirubicin—bone cancer	0.000282	0.0021	CcSEcCtD
Buspirone—Convulsion—Methotrexate—bone cancer	0.000282	0.0021	CcSEcCtD
Buspirone—Erythema—Doxorubicin—bone cancer	0.000281	0.00209	CcSEcCtD
Buspirone—Agitation—Epirubicin—bone cancer	0.00028	0.00208	CcSEcCtD
Buspirone—Flatulence—Doxorubicin—bone cancer	0.000277	0.00206	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—bone cancer	0.000277	0.00206	CcSEcCtD
Buspirone—Chest pain—Methotrexate—bone cancer	0.000277	0.00206	CcSEcCtD
Buspirone—Myalgia—Methotrexate—bone cancer	0.000277	0.00206	CcSEcCtD
Buspirone—Tension—Doxorubicin—bone cancer	0.000276	0.00206	CcSEcCtD
Buspirone—Dysgeusia—Doxorubicin—bone cancer	0.000276	0.00205	CcSEcCtD
Buspirone—Malaise—Epirubicin—bone cancer	0.000274	0.00204	CcSEcCtD
Buspirone—Discomfort—Methotrexate—bone cancer	0.000273	0.00203	CcSEcCtD
Buspirone—Nervousness—Doxorubicin—bone cancer	0.000273	0.00203	CcSEcCtD
Buspirone—Vertigo—Epirubicin—bone cancer	0.000273	0.00203	CcSEcCtD
Buspirone—Syncope—Epirubicin—bone cancer	0.000273	0.00203	CcSEcCtD
Buspirone—Leukopenia—Epirubicin—bone cancer	0.000272	0.00203	CcSEcCtD
Buspirone—Muscle spasms—Doxorubicin—bone cancer	0.000271	0.00201	CcSEcCtD
Buspirone—Palpitations—Epirubicin—bone cancer	0.000269	0.002	CcSEcCtD
Buspirone—Confusional state—Methotrexate—bone cancer	0.000267	0.00199	CcSEcCtD
Buspirone—Loss of consciousness—Epirubicin—bone cancer	0.000267	0.00199	CcSEcCtD
Buspirone—Vision blurred—Doxorubicin—bone cancer	0.000265	0.00197	CcSEcCtD
Buspirone—Convulsion—Epirubicin—bone cancer	0.000264	0.00196	CcSEcCtD
Buspirone—Hypertension—Epirubicin—bone cancer	0.000263	0.00195	CcSEcCtD
Buspirone—Ill-defined disorder—Doxorubicin—bone cancer	0.000261	0.00194	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—bone cancer	0.00026	0.00193	CcSEcCtD
Buspirone—Myalgia—Epirubicin—bone cancer	0.000259	0.00193	CcSEcCtD
Buspirone—Arthralgia—Epirubicin—bone cancer	0.000259	0.00193	CcSEcCtD
Buspirone—Chest pain—Epirubicin—bone cancer	0.000259	0.00193	CcSEcCtD
Buspirone—Agitation—Doxorubicin—bone cancer	0.000259	0.00192	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—bone cancer	0.000256	0.00191	CcSEcCtD
Buspirone—Discomfort—Epirubicin—bone cancer	0.000256	0.0019	CcSEcCtD
Buspirone—Malaise—Doxorubicin—bone cancer	0.000254	0.00189	CcSEcCtD
Buspirone—Dry mouth—Epirubicin—bone cancer	0.000253	0.00188	CcSEcCtD
Buspirone—Vertigo—Doxorubicin—bone cancer	0.000253	0.00188	CcSEcCtD
Buspirone—Anorexia—Methotrexate—bone cancer	0.000253	0.00188	CcSEcCtD
Buspirone—Syncope—Doxorubicin—bone cancer	0.000252	0.00188	CcSEcCtD
Buspirone—Leukopenia—Doxorubicin—bone cancer	0.000252	0.00187	CcSEcCtD
Buspirone—Confusional state—Epirubicin—bone cancer	0.00025	0.00186	CcSEcCtD
Buspirone—Palpitations—Doxorubicin—bone cancer	0.000249	0.00185	CcSEcCtD
Buspirone—Oedema—Epirubicin—bone cancer	0.000248	0.00185	CcSEcCtD
Buspirone—Hypotension—Methotrexate—bone cancer	0.000248	0.00184	CcSEcCtD
Buspirone—Loss of consciousness—Doxorubicin—bone cancer	0.000247	0.00184	CcSEcCtD
Buspirone—Shock—Epirubicin—bone cancer	0.000244	0.00182	CcSEcCtD
Buspirone—Convulsion—Doxorubicin—bone cancer	0.000244	0.00181	CcSEcCtD
Buspirone—Thrombocytopenia—Epirubicin—bone cancer	0.000243	0.00181	CcSEcCtD
Buspirone—Hypertension—Doxorubicin—bone cancer	0.000243	0.00181	CcSEcCtD
Buspirone—Tachycardia—Epirubicin—bone cancer	0.000242	0.0018	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000242	0.0018	CcSEcCtD
Buspirone—Hyperhidrosis—Epirubicin—bone cancer	0.00024	0.00179	CcSEcCtD
Buspirone—Insomnia—Methotrexate—bone cancer	0.00024	0.00179	CcSEcCtD
Buspirone—Myalgia—Doxorubicin—bone cancer	0.00024	0.00178	CcSEcCtD
Buspirone—Arthralgia—Doxorubicin—bone cancer	0.00024	0.00178	CcSEcCtD
Buspirone—Chest pain—Doxorubicin—bone cancer	0.00024	0.00178	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—bone cancer	0.000238	0.00177	CcSEcCtD
Buspirone—Discomfort—Doxorubicin—bone cancer	0.000237	0.00176	CcSEcCtD
Buspirone—Anorexia—Epirubicin—bone cancer	0.000237	0.00176	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—bone cancer	0.000236	0.00176	CcSEcCtD
Buspirone—Somnolence—Methotrexate—bone cancer	0.000236	0.00176	CcSEcCtD
Buspirone—Dry mouth—Doxorubicin—bone cancer	0.000234	0.00174	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—bone cancer	0.000234	0.00174	CcSEcCtD
Buspirone—Hypotension—Epirubicin—bone cancer	0.000232	0.00173	CcSEcCtD
Buspirone—Confusional state—Doxorubicin—bone cancer	0.000232	0.00172	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—bone cancer	0.000231	0.00172	CcSEcCtD
Buspirone—Oedema—Doxorubicin—bone cancer	0.00023	0.00171	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000229	0.0017	CcSEcCtD
Buspirone—Fatigue—Methotrexate—bone cancer	0.000229	0.0017	CcSEcCtD
Buspirone—Pain—Methotrexate—bone cancer	0.000227	0.00169	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000226	0.00168	CcSEcCtD
Buspirone—Shock—Doxorubicin—bone cancer	0.000226	0.00168	CcSEcCtD
Buspirone—Thrombocytopenia—Doxorubicin—bone cancer	0.000225	0.00167	CcSEcCtD
Buspirone—Insomnia—Epirubicin—bone cancer	0.000225	0.00167	CcSEcCtD
Buspirone—Tachycardia—Doxorubicin—bone cancer	0.000224	0.00167	CcSEcCtD
Buspirone—Paraesthesia—Epirubicin—bone cancer	0.000223	0.00166	CcSEcCtD
Buspirone—Hyperhidrosis—Doxorubicin—bone cancer	0.000222	0.00165	CcSEcCtD
Buspirone—Dyspnoea—Epirubicin—bone cancer	0.000221	0.00165	CcSEcCtD
Buspirone—Somnolence—Epirubicin—bone cancer	0.000221	0.00164	CcSEcCtD
Buspirone—Anorexia—Doxorubicin—bone cancer	0.000219	0.00163	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—bone cancer	0.000219	0.00163	CcSEcCtD
Buspirone—Dyspepsia—Epirubicin—bone cancer	0.000219	0.00163	CcSEcCtD
Buspirone—Decreased appetite—Epirubicin—bone cancer	0.000216	0.00161	CcSEcCtD
Buspirone—Hypotension—Doxorubicin—bone cancer	0.000215	0.0016	CcSEcCtD
Buspirone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000214	0.0016	CcSEcCtD
Buspirone—Fatigue—Epirubicin—bone cancer	0.000214	0.00159	CcSEcCtD
Buspirone—Constipation—Epirubicin—bone cancer	0.000212	0.00158	CcSEcCtD
Buspirone—Pain—Epirubicin—bone cancer	0.000212	0.00158	CcSEcCtD
Buspirone—Urticaria—Methotrexate—bone cancer	0.000211	0.00157	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—bone cancer	0.00021	0.00156	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000209	0.00156	CcSEcCtD
Buspirone—Insomnia—Doxorubicin—bone cancer	0.000208	0.00155	CcSEcCtD
Buspirone—Paraesthesia—Doxorubicin—bone cancer	0.000206	0.00154	CcSEcCtD
Buspirone—Dyspnoea—Doxorubicin—bone cancer	0.000205	0.00152	CcSEcCtD
Buspirone—Feeling abnormal—Epirubicin—bone cancer	0.000205	0.00152	CcSEcCtD
Buspirone—Somnolence—Doxorubicin—bone cancer	0.000204	0.00152	CcSEcCtD
Buspirone—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000204	0.00525	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—RGS1—bone cancer	0.000203	0.00522	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—GRM4—bone cancer	0.000203	0.00522	CbGpPWpGaD
Buspirone—Dyspepsia—Doxorubicin—bone cancer	0.000202	0.0015	CcSEcCtD
Buspirone—Decreased appetite—Doxorubicin—bone cancer	0.0002	0.00149	CcSEcCtD
Buspirone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000198	0.00148	CcSEcCtD
Buspirone—Fatigue—Doxorubicin—bone cancer	0.000198	0.00147	CcSEcCtD
Buspirone—Urticaria—Epirubicin—bone cancer	0.000197	0.00147	CcSEcCtD
Buspirone—Pain—Doxorubicin—bone cancer	0.000196	0.00146	CcSEcCtD
Buspirone—Constipation—Doxorubicin—bone cancer	0.000196	0.00146	CcSEcCtD
Buspirone—Body temperature increased—Epirubicin—bone cancer	0.000196	0.00146	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—bone cancer	0.000195	0.00145	CcSEcCtD
Buspirone—HTR2B—G alpha (q) signalling events—GNA11—bone cancer	0.000191	0.00492	CbGpPWpGaD
Buspirone—Asthenia—Methotrexate—bone cancer	0.00019	0.00142	CcSEcCtD
Buspirone—Feeling abnormal—Doxorubicin—bone cancer	0.000189	0.00141	CcSEcCtD
Buspirone—Pruritus—Methotrexate—bone cancer	0.000188	0.0014	CcSEcCtD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000186	0.00479	CbGpPWpGaD
Buspirone—Hypersensitivity—Epirubicin—bone cancer	0.000183	0.00136	CcSEcCtD
Buspirone—Urticaria—Doxorubicin—bone cancer	0.000182	0.00136	CcSEcCtD
Buspirone—Body temperature increased—Doxorubicin—bone cancer	0.000182	0.00135	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—bone cancer	0.000181	0.00135	CcSEcCtD
Buspirone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000179	0.0046	CbGpPWpGaD
Buspirone—Asthenia—Epirubicin—bone cancer	0.000178	0.00133	CcSEcCtD
Buspirone—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000176	0.00454	CbGpPWpGaD
Buspirone—Pruritus—Epirubicin—bone cancer	0.000176	0.00131	CcSEcCtD
Buspirone—Dizziness—Methotrexate—bone cancer	0.000175	0.00131	CcSEcCtD
Buspirone—HTR2B—GPCR ligand binding—GRM4—bone cancer	0.000173	0.00444	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000171	0.0044	CbGpPWpGaD
Buspirone—Diarrhoea—Epirubicin—bone cancer	0.00017	0.00126	CcSEcCtD
Buspirone—Hypersensitivity—Doxorubicin—bone cancer	0.000169	0.00126	CcSEcCtD
Buspirone—Vomiting—Methotrexate—bone cancer	0.000169	0.00126	CcSEcCtD
Buspirone—DRD3—Circadian rythm related genes—GNA11—bone cancer	0.000168	0.00432	CbGpPWpGaD
Buspirone—Rash—Methotrexate—bone cancer	0.000167	0.00124	CcSEcCtD
Buspirone—DRD3—Circadian rythm related genes—EZH2—bone cancer	0.000167	0.0043	CbGpPWpGaD
Buspirone—Dermatitis—Methotrexate—bone cancer	0.000167	0.00124	CcSEcCtD
Buspirone—Headache—Methotrexate—bone cancer	0.000166	0.00124	CcSEcCtD
Buspirone—Asthenia—Doxorubicin—bone cancer	0.000165	0.00123	CcSEcCtD
Buspirone—Dizziness—Epirubicin—bone cancer	0.000164	0.00122	CcSEcCtD
Buspirone—Pruritus—Doxorubicin—bone cancer	0.000163	0.00121	CcSEcCtD
Buspirone—DRD3—GPCR ligand binding—GRM4—bone cancer	0.000161	0.00413	CbGpPWpGaD
Buspirone—Vomiting—Epirubicin—bone cancer	0.000158	0.00117	CcSEcCtD
Buspirone—Nausea—Methotrexate—bone cancer	0.000158	0.00117	CcSEcCtD
Buspirone—Diarrhoea—Doxorubicin—bone cancer	0.000157	0.00117	CcSEcCtD
Buspirone—Rash—Epirubicin—bone cancer	0.000157	0.00116	CcSEcCtD
Buspirone—Dermatitis—Epirubicin—bone cancer	0.000156	0.00116	CcSEcCtD
Buspirone—Headache—Epirubicin—bone cancer	0.000156	0.00116	CcSEcCtD
Buspirone—Dizziness—Doxorubicin—bone cancer	0.000152	0.00113	CcSEcCtD
Buspirone—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.00015	0.00385	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—GRM1—bone cancer	0.00015	0.00385	CbGpPWpGaD
Buspirone—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000148	0.0038	CbGpPWpGaD
Buspirone—Nausea—Epirubicin—bone cancer	0.000147	0.0011	CcSEcCtD
Buspirone—Vomiting—Doxorubicin—bone cancer	0.000146	0.00109	CcSEcCtD
Buspirone—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000145	0.00373	CbGpPWpGaD
Buspirone—Rash—Doxorubicin—bone cancer	0.000145	0.00108	CcSEcCtD
Buspirone—Dermatitis—Doxorubicin—bone cancer	0.000145	0.00108	CcSEcCtD
Buspirone—Headache—Doxorubicin—bone cancer	0.000144	0.00107	CcSEcCtD
Buspirone—HTR1A—GPCR ligand binding—GRM4—bone cancer	0.00014	0.0036	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—GRM1—bone cancer	0.000139	0.00358	CbGpPWpGaD
Buspirone—Nausea—Doxorubicin—bone cancer	0.000136	0.00102	CcSEcCtD
Buspirone—HTR2A—G alpha (q) signalling events—GNA11—bone cancer	0.000134	0.00345	CbGpPWpGaD
Buspirone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00013	0.00335	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—GNA11—bone cancer	0.000129	0.00331	CbGpPWpGaD
Buspirone—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000128	0.0033	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—EZH2—bone cancer	0.000128	0.00329	CbGpPWpGaD
Buspirone—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000126	0.00325	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—GRM4—bone cancer	0.000123	0.00316	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—GRM1—bone cancer	0.000121	0.00312	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—GRM4—bone cancer	0.000121	0.00311	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.00012	0.00308	CbGpPWpGaD
Buspirone—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000108	0.00279	CbGpPWpGaD
Buspirone—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000107	0.00275	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—GRM1—bone cancer	0.000107	0.00274	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000107	0.00274	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—SMO—bone cancer	0.000105	0.00271	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—GRM1—bone cancer	0.000105	0.0027	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—SMO—bone cancer	9.81e-05	0.00253	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—GRM4—bone cancer	9.76e-05	0.00251	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—RGS1—bone cancer	9.76e-05	0.00251	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—CDK4—bone cancer	9.44e-05	0.00243	CbGpPWpGaD
Buspirone—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.26e-05	0.00238	CbGpPWpGaD
Buspirone—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	9.13e-05	0.00235	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—GRM4—bone cancer	9.08e-05	0.00234	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—RGS1—bone cancer	9.08e-05	0.00234	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	9.06e-05	0.00233	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—NDUFA12—bone cancer	8.98e-05	0.00231	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—RGS1—bone cancer	8.86e-05	0.00228	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—GRM4—bone cancer	8.86e-05	0.00228	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—SMO—bone cancer	8.55e-05	0.0022	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—GRM1—bone cancer	8.46e-05	0.00218	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.25e-05	0.00212	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—RGS1—bone cancer	8.24e-05	0.00212	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—GRM4—bone cancer	8.24e-05	0.00212	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—RGS1—bone cancer	7.91e-05	0.00204	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—GRM4—bone cancer	7.91e-05	0.00204	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—GRM1—bone cancer	7.87e-05	0.00203	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.7e-05	0.00198	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—GRM1—bone cancer	7.68e-05	0.00198	CbGpPWpGaD
Buspirone—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.59e-05	0.00195	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.51e-05	0.00193	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—SMO—bone cancer	7.51e-05	0.00193	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—NT5C3A—bone cancer	7.44e-05	0.00191	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.41e-05	0.00191	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—SMO—bone cancer	7.39e-05	0.0019	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—CDK4—bone cancer	7.22e-05	0.00186	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—GRM4—bone cancer	7.18e-05	0.00185	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—RGS1—bone cancer	7.18e-05	0.00185	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—GRM1—bone cancer	7.15e-05	0.00184	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	7.02e-05	0.00181	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—GRM4—bone cancer	6.95e-05	0.00179	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—RGS1—bone cancer	6.95e-05	0.00179	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—GRM1—bone cancer	6.86e-05	0.00177	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—GRM4—bone cancer	6.84e-05	0.00176	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—RGS1—bone cancer	6.84e-05	0.00176	CbGpPWpGaD
Buspirone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.65e-05	0.00171	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.59e-05	0.00169	CbGpPWpGaD
Buspirone—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.49e-05	0.00167	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	6.49e-05	0.00167	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NDUFA12—bone cancer	6.49e-05	0.00167	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—GRM4—bone cancer	6.31e-05	0.00162	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—RGS1—bone cancer	6.31e-05	0.00162	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.28e-05	0.00162	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.26e-05	0.00161	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—GRM1—bone cancer	6.23e-05	0.0016	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—RGS1—bone cancer	6.21e-05	0.0016	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—GRM4—bone cancer	6.21e-05	0.0016	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—JUN—bone cancer	6.08e-05	0.00157	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—GRM1—bone cancer	6.02e-05	0.00155	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—GRM1—bone cancer	5.93e-05	0.00153	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	5.61e-05	0.00144	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—GRM1—bone cancer	5.47e-05	0.00141	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—GNA11—bone cancer	5.45e-05	0.0014	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—SMO—bone cancer	5.41e-05	0.00139	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.41e-05	0.00139	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—GRM1—bone cancer	5.38e-05	0.00138	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NT5C3A—bone cancer	5.38e-05	0.00138	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GRM4—bone cancer	5.23e-05	0.00135	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—RGS1—bone cancer	5.23e-05	0.00135	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—GNA11—bone cancer	5.07e-05	0.00131	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—SMO—bone cancer	5.04e-05	0.0013	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—GNA11—bone cancer	4.95e-05	0.00127	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—IL3—bone cancer	4.94e-05	0.00127	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NDUFA12—bone cancer	4.9e-05	0.00126	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.87e-05	0.00125	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—RGS1—bone cancer	4.87e-05	0.00125	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GRM4—bone cancer	4.87e-05	0.00125	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.66e-05	0.0012	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—JUN—bone cancer	4.66e-05	0.0012	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NDUFA12—bone cancer	4.62e-05	0.00119	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—GNA11—bone cancer	4.61e-05	0.00119	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—IL3—bone cancer	4.6e-05	0.00118	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GRM1—bone cancer	4.54e-05	0.00117	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL3—bone cancer	4.49e-05	0.00115	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—GNA11—bone cancer	4.42e-05	0.00114	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—SMO—bone cancer	4.39e-05	0.00113	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.31e-05	0.00111	CbGpPWpGaD
Buspirone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.25e-05	0.00109	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RGS1—bone cancer	4.24e-05	0.00109	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GRM4—bone cancer	4.24e-05	0.00109	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GRM1—bone cancer	4.22e-05	0.00109	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL3—bone cancer	4.18e-05	0.00107	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NT5C3A—bone cancer	4.06e-05	0.00104	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—TP53—bone cancer	4.02e-05	0.00103	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—GNA11—bone cancer	4.01e-05	0.00103	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—IL3—bone cancer	4.01e-05	0.00103	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—GNA11—bone cancer	3.88e-05	0.000999	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—SMO—bone cancer	3.85e-05	0.000992	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NT5C3A—bone cancer	3.82e-05	0.000984	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—GNA11—bone cancer	3.82e-05	0.000983	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—SMO—bone cancer	3.79e-05	0.000976	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RGS1—bone cancer	3.73e-05	0.000959	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GRM4—bone cancer	3.73e-05	0.000959	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GRM1—bone cancer	3.68e-05	0.000947	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RGS1—bone cancer	3.67e-05	0.000944	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GRM4—bone cancer	3.67e-05	0.000944	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL3—bone cancer	3.64e-05	0.000937	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—GNA11—bone cancer	3.52e-05	0.000907	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—IL3—bone cancer	3.52e-05	0.000905	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—GNA11—bone cancer	3.47e-05	0.000892	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—IL3—bone cancer	3.46e-05	0.000891	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.45e-05	0.000889	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.41e-05	0.000878	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.33e-05	0.000857	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ENO2—bone cancer	3.26e-05	0.000839	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GRM1—bone cancer	3.23e-05	0.000831	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SMO—bone cancer	3.2e-05	0.000823	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL3—bone cancer	3.2e-05	0.000822	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GRM1—bone cancer	3.18e-05	0.000818	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL3—bone cancer	3.14e-05	0.000809	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—TP53—bone cancer	3.07e-05	0.000791	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—DHFR—bone cancer	3.02e-05	0.000778	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NDUFA12—bone cancer	3.02e-05	0.000777	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3e-05	0.000772	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SMO—bone cancer	2.97e-05	0.000766	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GNA11—bone cancer	2.92e-05	0.000752	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GNA11—bone cancer	2.83e-05	0.000727	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GNA11—bone cancer	2.72e-05	0.0007	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ATF1—bone cancer	2.72e-05	0.0007	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL3—bone cancer	2.65e-05	0.000682	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SMO—bone cancer	2.59e-05	0.000667	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CYP3A4—bone cancer	2.56e-05	0.000659	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ATF1—bone cancer	2.53e-05	0.000651	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NT5C3A—bone cancer	2.5e-05	0.000643	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL3—bone cancer	2.47e-05	0.000635	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GNA11—bone cancer	2.37e-05	0.00061	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.36e-05	0.000607	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ENO2—bone cancer	2.36e-05	0.000606	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SMO—bone cancer	2.28e-05	0.000586	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.27e-05	0.000583	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SMO—bone cancer	2.24e-05	0.000576	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ATF1—bone cancer	2.2e-05	0.000567	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GSTP1—bone cancer	2.19e-05	0.000564	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—DHFR—bone cancer	2.19e-05	0.000562	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL3—bone cancer	2.15e-05	0.000553	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.13e-05	0.000549	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.11e-05	0.000543	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GNA11—bone cancer	2.08e-05	0.000536	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GNA11—bone cancer	2.05e-05	0.000527	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GNA11—bone cancer	2.04e-05	0.000526	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IGF1R—bone cancer	1.98e-05	0.000511	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.98e-05	0.00051	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ATF1—bone cancer	1.94e-05	0.000498	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ATF1—bone cancer	1.9e-05	0.00049	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL3—bone cancer	1.89e-05	0.000486	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL3—bone cancer	1.86e-05	0.000478	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CYP3A4—bone cancer	1.85e-05	0.000477	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TGFBR2—bone cancer	1.84e-05	0.000473	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ENO2—bone cancer	1.78e-05	0.000457	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.73e-05	0.000445	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ENO2—bone cancer	1.68e-05	0.000431	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—DHFR—bone cancer	1.65e-05	0.000424	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.61e-05	0.000415	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.59e-05	0.000409	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GSTP1—bone cancer	1.58e-05	0.000408	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—DHFR—bone cancer	1.55e-05	0.0004	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KIT—bone cancer	1.55e-05	0.000398	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GNA11—bone cancer	1.54e-05	0.000397	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF1R—bone cancer	1.52e-05	0.000391	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.49e-05	0.000385	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—BRAF—bone cancer	1.45e-05	0.000374	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GNA11—bone cancer	1.45e-05	0.000374	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KIT—bone cancer	1.44e-05	0.00037	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.41e-05	0.000363	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP3A4—bone cancer	1.4e-05	0.00036	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—BRAF—bone cancer	1.35e-05	0.000348	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP3A4—bone cancer	1.32e-05	0.000339	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—EGFR—bone cancer	1.31e-05	0.000338	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KIT—bone cancer	1.25e-05	0.000323	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MDM2—bone cancer	1.22e-05	0.000314	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTP1—bone cancer	1.2e-05	0.000308	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—BRAF—bone cancer	1.18e-05	0.000303	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.14e-05	0.000294	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—bone cancer	1.14e-05	0.000292	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MDM2—bone cancer	1.13e-05	0.000292	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTP1—bone cancer	1.13e-05	0.00029	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KIT—bone cancer	1.1e-05	0.000283	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO2—bone cancer	1.1e-05	0.000282	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KIT—bone cancer	1.08e-05	0.000279	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—JUN—bone cancer	1.06e-05	0.000273	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BRAF—bone cancer	1.04e-05	0.000266	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—bone cancer	1.03e-05	0.000265	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BRAF—bone cancer	1.02e-05	0.000262	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—DHFR—bone cancer	1.02e-05	0.000261	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—bone cancer	1e-05	0.000258	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MDM2—bone cancer	9.88e-06	0.000254	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—bone cancer	9.87e-06	0.000254	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—JUN—bone cancer	9.85e-06	0.000254	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—bone cancer	9.59e-06	0.000247	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GNA11—bone cancer	9.5e-06	0.000244	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MDM2—bone cancer	8.68e-06	0.000223	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—JUN—bone cancer	8.59e-06	0.000221	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MDM2—bone cancer	8.54e-06	0.00022	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—bone cancer	8.36e-06	0.000215	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—bone cancer	8.33e-06	0.000214	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—bone cancer	8.21e-06	0.000211	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—bone cancer	7.75e-06	0.000199	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JUN—bone cancer	7.54e-06	0.000194	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JUN—bone cancer	7.42e-06	0.000191	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTP1—bone cancer	7.36e-06	0.000189	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—bone cancer	7.34e-06	0.000189	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—bone cancer	7.22e-06	0.000186	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—bone cancer	6.99e-06	0.00018	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—bone cancer	6.75e-06	0.000174	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—bone cancer	6.51e-06	0.000167	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—bone cancer	6.19e-06	0.000159	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—bone cancer	5.93e-06	0.000153	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—bone cancer	5.83e-06	0.00015	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—bone cancer	5.83e-06	0.00015	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—bone cancer	5.67e-06	0.000146	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—bone cancer	4.98e-06	0.000128	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—bone cancer	4.9e-06	0.000126	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—bone cancer	3.81e-06	9.82e-05	CbGpPWpGaD
